StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2013 it was $41.12M, up 277.6% from the year before. The highest annual figure on record is $41.12M in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2013Dec 31, 2013$41.12M+277.6%
FY2012Dec 31, 2012$10.89M-5.2%
FY2011Dec 31, 2011$11.48M-31.7%
FY2010Dec 31, 2010$16.81M-18.3%
FY2009Dec 31, 2009$20.56M–

More Filana Therapeutics figures

See a number that looks wrong?